Literature DB >> 12121879

Acid- and bile-induced PGE(2) release and hyperproliferation in Barrett's esophagus are COX-2 and PKC-epsilon dependent.

Baljeet S Kaur1, George Triadafilopoulos.   

Abstract

Barrett's esophagus (BE) results from acid and bile reflux and predisposes to cancer. To further understand the mechanisms of acid- and bile-induced hyperproliferation in BE, we investigated the release of PGE(2) in response to acid or bile salt exposure. Biopsies of esophagus, BE, and duodenum were exposed to a bile salt mixture as a 1-h pulse and compared with exposure to pH 7.4 for up to 24 h, and PGE(2) release, cyclooxygenase-2 (COX-2), and protein kinase C (PKC) expression were compared. Similar experiments were also performed with acidified media (pH 3.5) alone, in the presence or absence of bisindolylmaleimide (BIM), a selective PKC inhibitor, and NS-398, a COX-2 inhibitor. One-hour pulses of bile salts or acid significantly enhanced proliferation, COX-2 expression, and PGE(2) release in BE. In contrast, the combination pulse of acid and bile salts had no such effect. Treatment with either BIM or NS-398 led to a dramatic decrease in PGE(2) release in BE explants and a suppression of proliferation. The acid- or bile salt-mediated hyperproliferation is related to PGE(2) release. Acid- and bile salt-induced induction of COX-2 and PKC may explain, at least in part, the tumor-promoting effects of acid and bile in BE.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12121879     DOI: 10.1152/ajpgi.00543.2001

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  20 in total

Review 1.  How should Barrett's ulceration be treated?

Authors:  J H Peters; K K Wang
Journal:  Surg Endosc       Date:  2004-01-12       Impact factor: 4.584

Review 2.  Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?

Authors:  R C Fitzgerald
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

3.  miR-200 family expression is downregulated upon neoplastic progression of Barrett's esophagus.

Authors:  Cameron M Smith; David I Watson; Mary P Leong; George C Mayne; Michael Z Michael; Bas P L Wijnhoven; Damian J Hussey
Journal:  World J Gastroenterol       Date:  2011-02-28       Impact factor: 5.742

Review 4.  Role of chemoprophylaxis with either NSAIDs or statins in patients with Barrett's esophagus.

Authors:  Panagiotis Tsibouris; Erasmia Vlachou; Peter Edward Thomas Isaacs
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-02-06

5.  Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus.

Authors:  Katerina Dvorak; Claire M Payne; Melissa Chavarria; Lois Ramsey; Barbora Dvorakova; Harris Bernstein; Hana Holubec; Richard E Sampliner; Naihsuan Guy; Amanda Condon; Carol Bernstein; Sylvan B Green; Anil Prasad; Harinder S Garewal
Journal:  Gut       Date:  2006-12-04       Impact factor: 23.059

Review 6.  Barrett's esophagus and Barrett's carcinoma.

Authors:  Burkhard H A von Rahden; Hubert J Stein; Jörg R Siewert
Journal:  Curr Oncol Rep       Date:  2003-05       Impact factor: 5.075

7.  Chemoprotective effects of curcumin in esophageal epithelial cells exposed to bile acids.

Authors:  Matthew R Bower; Harini S Aiyer; Yan Li; Robert C G Martin
Journal:  World J Gastroenterol       Date:  2010-09-07       Impact factor: 5.742

Review 8.  Barrett esophagus: what a mouse model can teach us about human disease.

Authors:  Michael Quante; Julian A Abrams; Yoomi Lee; Timothy C Wang
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

Review 9.  History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus.

Authors:  Stuart Jon Spechler; Rebecca C Fitzgerald; Ganapathy A Prasad; Kenneth K Wang
Journal:  Gastroenterology       Date:  2010-01-18       Impact factor: 22.682

10.  The molecular pathogenesis of Barrett's esophagus: common signaling pathways in embryogenesis metaplasia and neoplasia.

Authors:  Jeffrey H Peters; N Avisar
Journal:  J Gastrointest Surg       Date:  2009-09-16       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.